Hemoglobin SC Disease

Phase 3 trials (1)

• ketamine

Phase 2 trials (8)

• busulfan
• prednisone
• tacrolimus
• hydroxyurea
• pegylated carboxyhemoglobin
• fludarabine
• pyroglutamic acid
• sodium chloride

Phase 1 trials (1)

• ancestim

Other trials (6)

• lymphocytes
• cyclophosphamide
• bortezomib
• autologous cd34+ cells
• rituximab
• cytarabine

Organization Involved with Phase 3 Indications (1)

• University of South Florida

Organization Involved with Phase 2 Indications (10)

• Nova Laboratories Limited
• Sangart
• National Heart, Lung, and Blood Institute (NHLBI)
• National Institute of Allergy and Infectious Diseases (NIAID)
• Baylor University
• University of London
• Harvard University
• University of The West Indies
• University of Texas at Houston
• St. Jude Children's Hospital

Organization Involved with Phase 1 Indications (3)

• Imara, Inc.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• IQVIA

Organization Involved with Other Experimental Indications (3)

• Thomas Jefferson University
• Aga Khan University
• Methodist Cancer Center, Houston, Texas